Recent Quotes (30 days)

You have no recent quotes
chg | %

Covalon Technologies Ltd  

(Public, CVE:COV)   Watch this stock  
Find more results for COV
+0.050 (7.14%)
Oct 9 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.75 - 0.75
52 week 0.57 - 1.87
Open 0.75
Vol / Avg. 10,600.00/5,884.00
Mkt cap 6.98M
P/E     -
Div/yield     -
EPS -0.11
Shares 9.31M
Beta -1.04
Inst. own     -
Aug 28, 2015
Q2 2015 Covalon Technologies Ltd Earnings Release

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -6.55% 26.51%
Operating margin -5.65% 26.96%
EBITD margin - 30.23%
Return on average assets -6.16% 35.24%
Return on average equity -9.27% 56.69%
CDP Score - -


Suite 106, 405 Britannia Road East
+1-905-5688400 (Phone)
+1-905-5685200 (Fax)

Website links


Covalon Technologies Ltd. is a researcher, developer, manufacturer and marketer of medical products intended for wound care and infection management. Its products include ColActive and ColActive Plus, which are collagen matrix dressings; IV Clear and SurgiClear, which is a line of antimicrobial clear silicone adhesive dressings with chlorhexidine and silver, and SilverCoat, which is a line of antimicrobial silicone foley catheters. The Company’s products are marketed to various health care providers, such as hospitals, wound care centers, burn centers and acute care facilities. Its technologies are used to prevent, detect and manage medical conditions, such as wound care, tissue repair, infection control, disease management, medical device coatings and biocompatibility. It sells under Covalon’s name. The Company has three platform technologies for medical devices: Collagen matrix, Antimicrobial silicone adhesive and Medical coating technology.

Officers and directors

Abe Schwartz Chairman of the Board
Brian E. Pedlar President, Chief Executive Officer, Interim Chief Financial Officer, Director
Valerio DiTizio Chief Scientific Officer
Kim Crooks Vice President - Operations
John Hands Senior Director - Global Marketing
Elinor Caplan Director
Martin C. Bernholtz Independent Director
Ian Brindle Independent Director
Joseph Cordiano Independent Director
Jeffrey A. Mandel Independent Director